PFM046 is the antagonist for liver X receptor ( LXR ), that inhibits the activation of LXRα and LXRβ with IC 50 of 2.04 μM and 1.58 μM. PFM046 inhibits the expression of SCD1 and FASN , upregulates the expression of ABCA1 , and exhibits antitumor efficacy in mouse models.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > LXR | Products > Signaling Pathways > Stearoyl-CoA Desaturase (SCD) | Products > Signaling Pathways > Fatty Acid Synthase (FASN)
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。